Altered Binding of Tumor Antigenic Peptides to MHC Class I Affects CD8+ T Cell–Effector ResponsesEleanor Clancy‐Thompson(Dana-Farber Cancer Institute), Stephanie K. Dougan(Harvard University)Cancer Immunology ResearchOctober 23, 201810.1158/2326-6066.cir-18-0348Cited by 26SaveCiteExport RISWatch citationsRelated PapersMolecular Pathways of Colon Inflammation Induced by Cancer Immunotherapy|Cell|2020|478NKG2A and HLA-E define an alternative immune checkpoint axis in bladder cancer|Cancer Cell|2022|127